The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis
Open accessAbstract
Variation in major histocompatibility complex genes on chromosome 6p21.3, specifically the human leukocyte antigen HLA-DR2 or DRB1*1501-DQB1*0602 extended haplotype, confers risk for multiple sclerosis (MS). Previous studies of DRB1 variation and both MS susceptibility and phenotypic expression have lacked statistical power to detect modest genotypic influences, and have demonstrated conflicting results. Results derived from analyses of 1339 MS families indicate DRB1 variation influences MS susceptibility in a complex manner. DRB1*15 was strongly associated in families (P=7.8x10(-31)), and a dominant DRB1*15 dose effect was confirmed (OR=7.5, 95% CI=4.4-13.0, P<0.0001). A modest dose effect was also detected for DRB1*03; however, in contrast to DRB1*15, this risk was recessive (OR=1.8, 95% CI=1.1-2.9, P=0.03). Strong evidence for under-transmission of DRB1*14 (P=5.7x10(-6)) even after accounting for DRB1*15 (P=0.03) was present, confirming a protective effect. In addition, a high risk DRB1*15 genotype bearing DRB1*08 was identified (OR=7.7, 95% CI=4.1-14.4, P<0.0001), providing additional evidence for trans DRB1 allelic interactions in MS. Further, a significant DRB1*15 association observed in primary progressive MS families (P=0.0004), similar to relapsing-remitting MS families, suggests that DRB1-related mechanisms are contributing to both phenotypes. In contrast, results obtained from 2201 MS cases argue convincingly that DRB1*15 genotypes do not modulate age of onset, or significantly influence disease severity measured using expanded disease disability score and disease duration. These results contribute substantially to our understanding of the DRB1 locus and MS, and underscore the importance of using large sample sizes to detect modest genetic effects, particularly in studies of genotype-phenotype relationships.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
PedCheck: A Program for Identification of Genotype Incompatibilities in Linkage Analysis
O'Connell, J. R., & Weeks, D. E. (1998) · The American Journal of Human Genetics · doi:10.1086/301904 · Cited by 2,056
ANKYLOSING SPONDYLITIS AND HL-A 27
Brewerton, D. A., Hart, F. D., Nicholls, A., Caffrey, M., James, D. C. O., & Sturrock, R. D. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91360-3 · Cited by 1,836
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
Lehmann, P. V., Forsthuber, T., Miller, A., & Sercarz, E. E. (1992) · Nature · doi:10.1038/358155a0 · Cited by 1,186
Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity
Roxburgh, R. H. S. R., Seaman, S. R., Masterman, T., Hensiek, A. E., Sawcer, S. J., Vukusic, S., Achiti, I., Confavreux, C., Coustans, M., le Page, E., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000156155.19270.f8 · Cited by 963
Self-citationA genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
Sawcer, S., Jones, H. B., Feakes, R., Gray, J., Smaldon, N., Chataway, J., Robertson, N., Clayton, D., Goodfellow, P. N., & Compston, A. (1996) · Nature Genetics · doi:10.1038/ng0896-464 · Cited by 643
Self-citationA Test for Linkage and Association in General Pedigrees: The Pedigree Disequilibrium Test
Martin, E. R., Monks, S. A., Warren, L. L., & Kaplan, N. L. (2000) · The American Journal of Human Genetics · doi:10.1086/302957 · Cited by 538
Kappos, L., Comi, G., Panitch, H., Oger, J., Antel, J., Conlon, P., Steinman, L., Comi, G., Kappos, L., Oger, J., et al. (2000) · Nature Medicine · doi:10.1038/80525 · Cited by 512
Primary progressive multiple sclerosis
Thompson, A. (1997) · Brain · doi:10.1093/brain/120.6.1085 · Cited by 506
Mapping disease genes: family-based association studies.
Thomson, G. (1995) · PubMed · Cited by 370
Self-citationDiagnostic criteria for primary progressive multiple sclerosis: a position paper.
Thompson, A. J., Montalbán, X., Barkhof, F., Brochet, B., Filippi, M., Miller, D. H., Polman, C. H., Stevenson, V. L., & McDonald, W. I. (2000) · PubMed · Cited by 352
Mapping Multiple Sclerosis Susceptibility to the HLA-DR Locus in African Americans
Oksenberg, J. R., Barcellos, L. F., Cree, B. A. C., Baranzini, S. E., Bugawan, T. L., Khan, O., Lincoln, R. R., Swerdlin, A., Mignot, E., Lin, L., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/380997 · Cited by 340
Self-citationLincoln, M. R., Montpetit, A., Cader, M. Z., Saarela, J., Dyment, D. A., Tiislar, M., Ferretti, V., Tienari, P. J., Sadovnick, A. D., Peltonen, L., et al. (2005) · Nature Genetics · doi:10.1038/ng1647 · Cited by 332
Yamasaki, K., Kira, J., Kawano, Y., Kobayashi, T., Kanai, T., Nishimura, Y., Matsushita, S., Hasuo, K., & Tobimatsu, S. (1996) · Annals of Neurology · doi:10.1002/ana.410400405 · Cited by 302
A High-Density Screen for Linkage in Multiple Sclerosis
(2005) · The American Journal of Human Genetics · doi:10.1086/444547 · Cited by 297
Fogdell‐Hahn, A., Ligers, A., Grønning, M., Hillert, J., & Olerup, O. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550205.x · Cited by 295
Smith, K. J., Pyrdol, J., Gauthier, L., Wiley, D. C., & Wucherpfennig, K. W. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1511 · Cited by 294
HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course
Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R. R., Bucher, P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367781 · Cited by 293
Self-citationHaines, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.8.1229 · Cited by 284
Self-citationMiretti, M. M., Walsh, E. C., Ke, X., Delgado, M., Griffiths, M., Hunt, S., Morrison, J., Whittaker, P., Lander, E. S., Cardon, L. R., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429393 · Cited by 256
Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance
Dyment, D. A., Herrera, B. M., Cader, M. Z., Willer, C. J., Lincoln, M. R., Sadovnick, A. D., Risch, N., & Ebers, G. C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi206 · Cited by 252
Cordell, H. J., Barratt, B. J., & Clayton, D. G. (2004) · Genetic Epidemiology · doi:10.1002/gepi.10307 · Cited by 223 · cited 4×
“Pseudocontrols were derived from non-transmitted parental alleles (32).”
BackgroundMethodInfluentialMarrosu, M. G., Murru, R., Murru, M. R., Costa, G., Zavattari, P., Whalen, M., Cocco, E., Mancosu, C., Schirru, L., Solla, E., et al. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2907 · Cited by 180
An Integrated Haplotype Map of the Human Major Histocompatibility Complex
Walsh, E. C., Mather, K. A., Schaffner, S. F., Farwell, L., Daly, M. J., Patterson, N., Cullen, M., Carrington, M., Bugawan, T. L., Erlich, H., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/378101 · Cited by 173
Self-citationHLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis
Hensiek, A. E. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.184 · Cited by 167
Correcting for a Potential Bias in the Pedigree Disequilibrium Test
Martin, E. R., Bass, M. P., & Kaplan, N. L. (2001) · The American Journal of Human Genetics · doi:10.1086/319525 · Cited by 163
Genetic basis for clinical expression in multiple sclerosis
The Multiple Sclerosis Genetics Group, Barcellos, L. F., Oksenberg, J. R., Green, A. J., Bucher, P., Rimmler, J. B., Schmidt, S., Garcia, M., Lincoln, R., Pericak‐Vance, M. A., et al. (2002) · Brain · doi:10.1093/brain/awf009 · Cited by 157
Self-citationMultiple Sclerosis and Other Demyelinating Diseases
Al-Tubaikh, J. A. (2010) · Springer eBooks · doi:10.1007/978-3-642-03709-2_13 · Cited by 156
Genetic predisposition to multiple sclerosis as revealed by immunoprinting
Epplen, C., Jäckel, S., dos Santos, E. J. M., D’Souza, M., Poehlau, D., Dotzauer, B., Sindern, E., Haupts, M. R., Rüde, K., Weber, F., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410410309 · Cited by 152
Major histocompatibility complex class II alleles and the course and outcome of MS
Weinshenker, B. G., Santrach, P. J., Bissonet, A. S., McDonnell, S. K., Schaid, D. J., Moore, S. B., & Rodríguez, M. T. (1998) · Neurology · doi:10.1212/wnl.51.3.742 · Cited by 152
Multiple sclerosis genetics: leaving no stone unturned
Oksenberg, J. R., & Barcellos, L. F. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364237 · Cited by 134
Self-citationSchmidt, S., Barcellos, L. F., DeSombre, K., Rimmler, J. B., Lincoln, R., Bucher, P., Saunders, A. M., Lai, E., Martin, E. R., Vance, J. M., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339269 · Cited by 133
Self-citationThe pathology of primary progressive multiple sclerosis
Lucchinetti, C. F., & Brück, W. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1027oa · Cited by 125
Genotype‐based association test for general pedigrees: The genotype‐PDT
Martin, E. R., Bass, M. P., Gilbert, J. R., Pericak‐Vance, M. A., & Hauser, E. R. (2003) · Genetic Epidemiology · doi:10.1002/gepi.10258 · Cited by 122
Self-citationIdentifying disease modifying genes in multiple sclerosis
Kantarci, O. H., de Andrade, M., & Weinshenker, B. G. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00481-7 · Cited by 121
Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis
Celius, E. G., Harbo, H. F., EGELAND, T., Vartdal, F., Vandvik, B., & Spurkland, A. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00389-0 · Cited by 116
Sawcer, S. J., Maranian, M. J., Setakis, E., Curwen, V., Akesson, E., Hensiek, A. E., Coraddu, F., Roxburgh, R. H., Sawcer, D., Gray, J., et al. (2002) · Brain · doi:10.1093/brain/awf143 · Cited by 111
Self-citationClinical study of primary progressive multiple sclerosis in Northern Ireland, UK
McDonnell, G. V., & Hawkins, S. A. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.4.451 · Cited by 101
Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity
Stratmann, T., Martín‐Orozco, N., Mallet-Designe, V., Poirot, L., McGavern, D. B., Losyev, G., Dobbs, C. M., Oldstone, M. B. A., YOSHIDA, K., Kikutani, H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18337 · Cited by 96
Rubio, J. P., Bahlo, M., Butzkueven, H., van der Mei, I. A. F., Sale, M. M., Dickinson, J. L., Groom, P., Johnson, L., Simmons, R. D., Tait, B. D., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339932 · Cited by 94
HLA-DR and -DQ Associations with Multiple Sclerosis in Turkey
Saruhan‐Direskeneli, G., Esin, S., Baykan, B. B., Örnek, I., Vaughan, R., & Eraksoy, M. (1997) · Human Immunology · doi:10.1016/s0198-8859(97)00086-4 · Cited by 94
HLA Class II Susceptibility to Multiple Sclerosis Among Ashkenazi and Non-Ashkenazi Jews
Kwon, O. J., Karni, A., Israel, S., Brautbar, C., Amar, A., Meiner, Z., Abramsky, O., & Karussis, D. M. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.555 · Cited by 82
Current approved options for treating patients with multiple sclerosis
Rizvi, S., & Agius, M. A. (2004) · Neurology · doi:10.1212/wnl.63.12_suppl_6.s8 · Cited by 77
Evidence of Linkage with HLA-DR in DRB1*15-Negative Families with Multiple Sclerosis
Ligers, A., Dyment, D. A., Willer, C. J., Sadovnick, A. D., Ebers, G. C., RISCH, N. J., & Hillert, J. A. (2001) · The American Journal of Human Genetics · doi:10.1086/323480 · Cited by 76
Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis
Weinshenker, B. G., Wingerchuk, D. M., Liu, Q., Bissonet, A. S., Schaid, D. J., & Sommer, S. S. (1997) · Neurology · doi:10.1212/wnl.49.2.378 · Cited by 75
Villoslada, P., Barcellos, L. F., Río, J., Begovich, A. B., Tintoré, M., Sastre‐Garriga, J., Baranzini, S. E., Casquero, P., Hauser, S. L., Montalbán, X., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00215-1 · Cited by 75
Self-citationMcDonnell, G. V., Mawhinney, H., Graham, C. A., Hawkins, S. A., & Middleton, D. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00084-2 · Cited by 72
HLA associations with multiple sclerosis in the Canary Islands
Coraddu, F., Reyes-Yanez, M. P., Parra, A. G. M., Gray, J., Smith, S. I., Taylor, C. J., & Compston, D. A. S. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00074-5 · Cited by 69
Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region
de Jong, B. A., Huizinga, T. W. J., Zanelli, E. H., Giphart, M. J., Bollen, E. L. E. M., Uitdehaag, B. M. J., Polman, C. H., & Westendorp, R. G. J. (2002) · Neurology · doi:10.1212/wnl.59.4.549 · Cited by 61
HLA typing in the United Kingdom multiple sclerosis genome screen
Coraddu, F., Sawcer, S. J., Feakes, R. W., Chataway, J., Broadley, S., Jones, H. B., Clayton, D. G., Gray, J., Smith, S. I., Taylor, C. J., et al. (1998) · Neurogenetics · doi:10.1007/s100480050048 · Cited by 59
Self-citationThe HLA locus and multiple sclerosis in Sicily
Brassat, D., Salemi, G., Barcellos, L. F., McNeill, G., Proia, P., Hauser, S. L., Oksenberg, J. R., & Savettieri, G. (2005) · Neurology · doi:10.1212/01.wnl.0000149765.71212.0a · Cited by 55
Self-citationTraherne, J. A., Barcellos, L. F., Sawcer, S. J., Compston, A., Ramsay, P. P., Hauser, S. L., Oksenberg, J. R., & Trowsdale, J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi436 · Cited by 47
Self-citationQuelvennec, E., Béra, O., Cabre, P., Alizadeh, M., Smadja, D., Jugdé, F., Edan, G., & Sémana, G. (2003) · Tissue Antigens · doi:10.1046/j.0001-2815.2002.00008.x · Cited by 38
Modes of Action of HLA-DR Susceptibility Specificities in Multiple Sclerosis
Modin, H., Olsson, W., Hillert, J. A., & Masterman, T. (2004) · The American Journal of Human Genetics · doi:10.1086/420977 · Cited by 38
Khare, M., Mangalam, A. K., Rodriguez, M., & David, C. S. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.023 · Cited by 37
Multiple sclerosis in the tropics: genetic association to STR’s loci spanning the HLA and TNF
Palacio, L. G., Rivera, D., Builes, J. J., Jiménez, M. E., Salgar, M., Anaya, J., Jiménez, I., Camargo, M., Arcos‐Burgos, M., & Sánchez, J. L. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms804oa · Cited by 23
Wucherpfennig, K. W. (2006) · Springer eBooks · doi:10.1007/3-540-30791-5_2 · Cited by 22
Lie, B. A., Akselsen, H. E., Bowlus, C. L., Gruen, J. R., Thorsby, E., & Undlien, D. E. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363858 · Cited by 22
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
Cited by
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
“In addition, the analysis also explains why those haplotypes carrying the *08:01 allele have previously been shown to increase ris”
Primary-progressive multiple sclerosis
Miller, D. H., & Leary, S. M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70243-0 · Cited by 818
International MS Genetics Consortium, De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Piccio, L., Raychaudhuri, S., Tran, D., et al. (2009) · Nature Genetics · doi:10.1038/ng.401 · Cited by 800
Self-citationThe Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
Self-citationMultiple sclerosis: risk factors, prodromes, and potential causal pathways
Ramagopalan, S. V., Dobson, R., Meier, U. C., & Giovannoni, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70094-6 · Cited by 548
Metadata
- Authors
- Barcellos, L. F., Sawcer, S., Ramsay, P. P., Baranzini, S. E., Thomson, G., Briggs, F., Cree, B. C. A., Begovich, A. B., Villoslada, P., Montalban, X., Uccelli, A., Savettieri, G., Lincoln, R. R., DeLoa, C., Haines, J. L., Pericak-Vance, M. A., Compston, A., Hauser, S. L., & Oksenberg, J. R.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09-15
- Volume
- 15
- Issue
- 18
- Pages
- 2813-2824
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2111536363
- Cited by
- 317
- References
- 60
- FWCI
- 17.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.